Following the hugely successful Serialisation Forum run by PCI and Partners in January 2017, we are back this November to share our experiences in achieving compliance on projects throughout the year.
Drug counterfeiting is on the rise globally and regulatory deadlines, notably the EU-FMD, are approaching fast.
The pharmaceutical supply chain will soon be at a critical point to ensure patient safety. From drug manufacturers to distributors, all supply chain partners will need to make crucial decisions to upgrade their production lines in compliance with traceability deadlines.
Despite the US regulatory timescales being delayed until 2018, non-US regulatory deadlines remain set and so the pharmaceutical supply chain continues to be at a critical point. All stakeholders including drug manufacturers and outsourcing suppliers will need to ensure that robust plans are in place to upgrade their production lines in compliance with DSCSA, EU Falsified Medicines Directive (FMD), and emerging market traceability deadlines.
Bring your queries and ask the experts
This November 21st, PCI Pharma Services along with Crest Solutions, Antares Vision, Xyntek and Multi Packaging Solutions are pleased to invite you to their free educational Serialisation and Anti-Counterfeiting Forum at Heathrow, London.
Antares Vision is responsible for the compliance of over 1,200 serialised lines globally. Crest Solutions and our sister company VistaLink are the exclusive partners of Antares Vision in the UK, Ireland, Benelux and Scandinavia. We integrate, service and support Antares Vision solutions in our geographical regions, working closely with our embedded team members in Antares Vision HQ to deliver projects seamlessly.
On November 21st, you will meet the brightest and most experienced minds in the pharma anti-counterfeiting industry who will come together to share with you their experiences and best practices for executing your serialisation strategy.